Sylvan Labs

Hiring activelyEnterprise · Sales & CXAI-native

Building revenue superagents.

sylvanlabs.com · San Francisco, CA

Source Form DCIK 0002152408as of 2026-10-03

Funding event

The round itself, as filed
Inferred stageSeries A
Sold of offered$10.9M of $10.9M
Filed2026-09-02
Days since filing31
Exemption claimed
Rule 506(b)
First-ever Form D
Yes
Date of first sale
2026-08-03
Investors

No investors named: Form D does not list them

Exemption is the box the issuer checked, not our judgement.

Officers on the filing

Names and roles as filed; addresses are never stored
  • Charles LiExecutive Officer · Director
  • Shangyan LiDirector
  • Ziv WangenheimDirector
Form D item 3. Related-person addresses stay in the raw filing and appear in no export, API or alert.

Health flags

Three flags, each with the raw inputs behind it · as of 2026-10-03
UndersubscribedNot flagged100% sold2 months since first sale
Prior raiseNot flaggedPrior raise not known—
AmendedNot flaggedNo amendmentNo D/A on file

Open roles

On the employer's own careers page · checked 2026-09-21
2

Pre-posting windowNot enough dataShown once this sector and stage have 20 observed lags from filing to first posting.

Roles link to the employer's own page; Noctura shows titles only.

Looking for a role? Role discovery opens when there are enough postings to be honest about it.

Also raised in Enterprise

Same sector, 28 days to 2026-10-04
Suite StudiosSeries A · $13.0M of $13.0M · Boulder, COHiring activelyMiterSeries B · $40.0M · San Francisco, CAQuiet

25 rounds in Enterprise in the 28 days to 2026-10-02, against 32 in the 28 days before.

Every Monday

The week, written up

Start Signals